Genetically Modified T-Lymphocyte Therapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Genetically Modified T-Lymphocyte Therapy, covering 2017-10-09 to 2017-10-09. Get the full timeline:
Most recent: Clinical Trial Update: Cellular Adoptive Immunotherapy Using Genetically Modified T-Lymphocytes in Treating Patients With Recurrent or Refractory High-Grade Malignant Glioma [Phase 1]